Editas Medicine Inc

2026-09-21 21:51; UTC

Editas Medicine Inc is trading higher in after-market hours, recovering from significant volatility, but remains 2.00% below its 20-day moving average.

2026-09-18 21:51; UTC

Editas Medicine Inc is advancing in after-market trading, moving higher alongside the broader market amid macroeconomic concerns and geopolitical tensions.

2026-09-17 23:01; UTC

Editas Medicine Inc is higher in after-market trading, recovering from earlier lows, though it remains below its 20-day moving average.

2026-09-16 20:07; UTC

Editas Medicine Inc is gaining in Wednesday's session, reflecting a positive trend since Tuesday's close, despite remaining below its 20-day moving average.

2026-09-15 23:51; UTC

Editas Medicine Inc shares are higher in after-market trading. No specific company news was identified to explain this price movement.

2026-09-10 20:08; UTC

Editas Medicine Inc shares are lower, extending a three-day decline amid broader biotechnology sector weakness and pressures from the European Central Bank's recent interest rate hike.

2026-09-09 22:11; UTC

Editas Medicine Inc shares are higher in after-market trading, reflecting a notable increase since Wednesday's close, despite being below its 20-day moving average.

2026-09-08 20:08; UTC

Editas Medicine appoints Dan Ory as Chief Medical Officer, shares decline sharply amid market response. The stock has reached a session low today.

2026-09-04 23:02; UTC

Editas Medicine Inc shares are lower during after-market hours, reflecting a decline despite being above its 20-day moving average and near one-month highs.

2026-09-01 19:16; UTC

Editas Medicine is participating in two investor conferences, enhancing visibility. Shares are higher today, reflecting positive investor interest in its CRISPR technology focus.

2026-08-31 22:51; UTC

Editas Medicine has filed a prospectus for a $400 million mixed securities shelf offering, contributing to higher shares during after-market hours.

2026-08-28 20:03; UTC

Editas Medicine Inc shares are lower today, retracing from earlier highs. Broader market dynamics, including rising Treasury yields, may be contributing to the decline.

2026-08-27 23:02; UTC

Editas Medicine Inc is trading higher in after-market hours, reflecting positive sentiment since Thursday's close and resilience despite earlier session pullbacks.

2026-08-26 23:16; UTC

Editas Medicine Inc shares are higher in after-market trading, positioned near the upper end of their one-month range and above the 20-day moving average.

2026-08-25 19:21; UTC

Editas Medicine Inc is seeing gains during Tuesday's session, reaching a peak return earlier before pulling back slightly. Broader market sentiment remains favorable for biotech stocks.

2026-08-24 22:22; UTC

Editas Medicine Inc shares are higher in after-market trading, showing some volatility. No specific news was identified to explain the price movement.

2026-08-21 23:16; UTC

Editas Medicine Inc shares are lower in after-market trading. No specific news was identified to explain the decline, though the stock remains above its 20-day moving average.

2026-08-20 23:46; UTC

Editas Medicine Inc is higher in after-market hours, gaining since Thursday's close. The stock is above its 20-day moving average amid no specific news.

2026-08-19 23:21; UTC

Editas Medicine Inc. shares are lower in after-market hours, impacted by a decline in the Biotechnology sub-sector. No specific news was identified for the movement.

2026-08-17 19:16; UTC

Editas Medicine Inc. shares are trading roughly flat amid overall market sentiment influenced by recent declines in U.S. retail sales and consumer sentiment.

2026-08-14 22:21; UTC

Editas Medicine Inc is trading lower in after-market hours, continuing a decline over the past four sessions amid broader concerns over consumer demand.

2026-08-13 21:32; UTC

Editas Medicine Inc advanced in after-hours trading, reflecting a shift in investor sentiment and aligning with a positive trend in the biotechnology sector.

2026-08-12 19:31; UTC

Editas Medicine Inc shares are lower today, continuing a decline since Tuesday. No specific news has been identified to explain the drop.

2026-08-11 19:46; UTC

Editas Medicine Inc shares are trading higher today, reflecting unusual strength. No specific company news was identified to explain this price action.

2026-08-10 23:26; UTC

Editas Medicine Inc shares are higher in after-market hours. No specific company news was identified to explain this movement amid broader market uncertainties.

2026-08-07 23:16; UTC

Editas Medicine Inc. shares were little changed in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.

2026-08-06 23:02; UTC

Editas Medicine Inc shares are higher in after-market hours, reflecting positive momentum following a strong trading session despite no specific company news.

2026-08-05 22:02; UTC

Editas Medicine reports second-quarter loss of $18.2 million, better than expected. Shares are higher after positive updates on EDIT-401 program and revenue growth.

2026-07-31 19:56; UTC

EDIT shares lower amid broader biotech sector decline today.

2026-07-30 23:51; UTC

Editas Medicine Inc shares are lower in after-market trading, continuing a decline since Thursday's close while remaining near the lower end of its one-month range.